ERBB2 and breast cancer: HER2/neu IgE-sensitized MCs labeled with CellBrite® (Figure 2B) or WGA (Figure 2C) demonstrated the formation of TnT from the plasma membrane of MCs following FcεRI-bound IgE binding to BC antigens.